高剂量伏美替尼在耐药性EGFR突变型NSCLC中的应用进展

曾娇, 丁江华

Application progress of high-dose furmonertinib in NSCLC with drug-resistant EGFR mutation

Zeng Jiao, Ding Jianghua

国际肿瘤学杂志 . 2026, (8): 491 -495 . DOI: 10.3760/cma.j.cn371439-20250929-00079